Egypt Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018

231 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
231
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Egypt Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018

  1. 1. Egypt Cardiovascular Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 344Price: Single User License – US$2500Egypt Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, “Egypt Cardiovascular Devices Investment Opportunities,Analysis and Forecasts to 2018” provides key market data on the Egypt Cardiovascular Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within ten market categories – Cardiac Rhythm Management,Interventional Cardiology, Cardiovascular Surgery, Peripheral Vascular Devices, Prosthetic HeartValves, Cardiovascular Monitoring and Diagnostic Devices, Electrophysiology, CardiovascularProsthetic Devices, Cardiac Assist Devices and External Defibrillators. The report also providescompany shares and distribution shares data for each of the aforementioned market categories.The report is supplemented with global corporate-level profiles of the key market participants withinformation on company financials and pipeline products, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Cardiovascular Devices market categories – CardiacRhythm Management, Interventional Cardiology, Cardiovascular Surgery, Peripheral VascularDevices, Prosthetic Heart Valves, Cardiovascular Monitoring and Diagnostic Devices,Electrophysiology, Cardiovascular Prosthetic Devices, Cardiac Assist Devices and ExternalDefibrillators.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within ten market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the ten market categories.
  2. 2. - Global corporate-level profiles of key companies operating within the Egypt CardiovascularDevices market.- Key players covered include Medtronic, Inc, Boston Scientific Corporation , St. Jude Medical,Inc., Abbott Laboratories, Sorin S.p.A., Cordis Corporation and others.Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Egypt CardiovascularDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195355-egypt-cardiovascular-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 91.2 List of Figures 142 Introduction 192.1 What is This Report About? 193 Cardiovascular Devices In Egypt 203.1 Cardiovascular Devices, Egypt, Overall Revenue ($m), USD Constant, 2004-2018 203.2 Cardiovascular Devices, Egypt, Company Share (2010-2011) 264 Cardiac Assist Devices In Egypt 284.1 Cardiac Assist Devices Overall Revenue, (2004-2018) 284.1.1 Intra-Aortic Balloon Pumps, Revenue (2004-2018) 324.1.2 Ventricular Assist Devices, Revenue (2004-2018) 364.2 Cardiac Assist Devices Overall Volume (2004-2018) 404.2.1 Intra-Aortic Balloon Pumps, Volume (2004-2018) 424.2.2 Ventricular Assist Devices, Volume (2004-2018) 454.3 Cardiac Assist Devices Average Price (2004-2018) 474.4 Cardiac Assist Devices Distribution Share (2010-2011) 484.5 Cardiac Assist Devices, Egypt, Company Share (2010-2011) 495 Cardiac Rhythm Management In Egypt 515.1 Cardiac Rhythm Management Overall Revenue, (2004-2018) 51
  3. 3. 5.1.1 Cardiac Resynchronisation Therapy, Revenue (2004-2018) 555.1.2 Implantable Cardioverter Defibrillators, Revenue (2004-2018) 595.1.3 Pacemakers, Revenue (2004-2018) 635.2 Cardiac Rhythm Management Overall Volume (2004-2018) 675.2.1 Cardiac Resynchronisation Therapy, Volume (2004-2018) 715.2.2 Implantable Cardioverter Defibrillators, Volume (2004-2018) 755.2.3 Pacemakers, Volume (2004-2018) 795.3 Cardiac Rhythm Management Average Price (2004-2018) 825.4 Cardiac Rhythm Management Distribution Share (2010-2011) 845.5 Cardiac Rhythm Management, Egypt, Company Share (2010-2011) 856 Cardiovascular Monitoring and Diagnostic Devices In Egypt 876.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue, (2004-2018) 876.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2004-2018) 916.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2004-2018) 956.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2010-2011) 966.5 Cardiovascular Monitoring and Diagnostic Devices, Egypt, Company Share (2010-2011) 977 Cardiovascular Prosthetic Devices In Egypt 997.1 Cardiovascular Prosthetic Devices Overall Revenue, (2004-2018) 997.1.1 Septal Occluders, Revenue (2004-2018) 1037.2 Cardiovascular Prosthetic Devices Overall Volume (2004-2018) 1077.2.1 Septal Occluders, Volume (2004-2018) 1117.3 Cardiovascular Prosthetic Devices Average Price (2004-2018) 1157.4 Cardiovascular Prosthetic Devices Distribution Share (2010-2011) 1167.5 Cardiovascular Prosthetic Devices, Egypt, Company Share (2010-2011) 1178 Cardiovascular Surgery In Egypt 1198.1 Cardiovascular Surgery Overall Revenue, (2004-2018) 1198.1.1 Beating Heart Surgery Systems, Revenue (2004-2018) 1238.1.2 Perfusion Disposables, Revenue (2004-2018) 1278.2 Cardiovascular Surgery Overall Volume (2004-2018) 1318.2.1 Beating Heart Surgery Systems, Volume (2004-2018) 1358.2.2 Perfusion Disposables, Volume (2004-2018) 1398.3 Cardiovascular Surgery Average Price (2004-2018) 1438.4 Cardiovascular Surgery Distribution Share (2010-2011) 1448.5 Cardiovascular Surgery, Egypt, Company Share (2010-2011) 1459 Electrophysiology In Egypt 1479.1 Electrophysiology Overall Revenue, (2004-2018) 1479.1.1 Electrophysiology Diagnostic Catheters, Revenue (2004-2018) 1519.1.2 Electrophysiology Ablation Catheters, Revenue (2004-2018) 1559.2 Electrophysiology Overall Volume (2004-2018) 1599.2.1 Electrophysiology Diagnostic Catheters, Volume (2004-2018) 1629.2.2 Electrophysiology Ablation Catheters, Volume (2004-2018) 1669.3 Electrophysiology Average Price (2004-2018) 170
  4. 4. 9.4 Electrophysiology Distribution Share (2010-2011) 1719.5 Electrophysiology, Egypt, Company Share (2010-2011) 17210 External Defibrillators In Egypt 17410.1 External Defibrillators Overall Revenue, (2004-2018) 17410.2 External Defibrillators Overall Volume (2004-2018) 17810.3 External Defibrillators Average Price (2004-2018) 18210.4 External Defibrillators Distribution Share (2010-2011) 18310.5 External Defibrillators, Egypt, Company Share (2010-2011) 18411 Interventional Cardiology In Egypt 18611.1 Interventional Cardiology Overall Revenue, (2004-2018) 18611.1.1 Cardiac Catheters, Revenue (2004-2018) 19011.1.2 Coronary Stents, Revenue (2004-2018) 19411.1.3 PTCA Balloons, Revenue (2004-2018) 19811.1.4 Arteriotomy Closure Devices, Revenue (2004-2018) 20211.1.5 Intravascular Ultrasound Systems (IVUS), Revenue (2004-2018) 20611.2 Interventional Cardiology Overall Volume (2004-2018) 21011.2.1 Cardiac Catheters, Volume (2004-2018) 21411.2.2 Coronary Stents, Volume (2004-2018) 21711.2.3 PTCA Balloons, Volume (2004-2018) 22011.2.4 Arteriotomy Closure Devices, Volume (2004-2018) 22411.2.5 Intravascular Ultrasound Systems (IVUS), Volume (2004-2018) 22811.3 Interventional Cardiology Average Price (2004-2018) 23211.4 Interventional Cardiology Distribution Share (2010-2011) 23411.5 Interventional Cardiology, Egypt, Company Share (2010-2011) 23512 Peripheral Vascular Devices In Egypt 23712.1 Peripheral Vascular Devices Overall Revenue, (2004-2018) 23712.1.1 Stent Grafts, Revenue (2004-2018) 24112.1.2 Inferior Vena Cava Filters (IVCF), Revenue (2004-2018) 24512.1.3 Peripheral Guidewires, Revenue (2004-2018) 24912.1.4 Peripheral Vascular Stents, Revenue (2004-2018) 25312.1.5 Peripheral Embolic Protection Devices, Revenue (2004-2018) 25712.2 Peripheral Vascular Devices Overall Volume (2004-2018) 26112.2.1 Stent Grafts, Volume (2004-2018) 26512.2.2 Inferior Vena Cava Filters (IVCF), Volume (2004-2018) 26812.2.3 Inferior Vena Cava Filters (IVCF), Volume (2004-2018) 27012.2.4 Peripheral Guidewires, Volume (2004-2018) 27312.2.5 Peripheral Vascular Stents, Volume (2004-2018) 27512.2.6 Peripheral Embolic Protection Devices, Volume (2004-2018) 27912.3 Peripheral Vascular Devices Average Price (2004-2018) 28312.4 Peripheral Vascular Devices Distribution Share (2010-2011) 28512.5 Peripheral Vascular Devices, Egypt, Company Share (2010-2011) 28613 Prosthetic Heart Valves In Egypt 288
  5. 5. 13.1 Prosthetic Heart Valves Overall Revenue, (2004-2018) 28813.1.1 Mechanical Heart Valves, Revenue (2004-2018) 29213.1.2 Tissue Heart Valves, Revenue (2004-2018) 29613.2 Prosthetic Heart Valves Overall Volume (2004-2018) 30013.2.1 Mechanical Heart Valves, Volume (2004-2018) 30213.2.2 Tissue Heart Valves, Volume (2004-2018) 30513.3 Prosthetic Heart Valves Average Price (2004-2018) 30813.4 Prosthetic Heart Valves Distribution Share (2010-2011) 30913.5 Prosthetic Heart Valves, Egypt, Company Share (2010-2011) 31014 Overview of Key Companies in Egypt Cardiovascular Devices Market 31214.1 Medtronic, Inc. 31214.1.1 Company Overview 31214.2 Boston Scientific Corporation 31214.2.1 Company Overview 31214.3 St. Jude Medical, Inc. 31314.3.1 Company Overview 31314.4 Abbott Laboratories 31314.4.1 Company Overview 31314.5 Sorin S.p.A. 31414.5.1 Company Overview 31414.6 Cordis Corporation 31414.6.1 Company Overview 31414.7 Biotronik SE & Co. KG 31514.7.1 Company Overview 31514.8 Terumo Corporation 31514.8.1 Company Overview 31514.9 MAQUET GmbH & Co. KG 31514.9.1 Company Overview 31514.10 Biosense Webster, Inc. 31614.10.1 Company Overview 31614.11 Edwards Lifesciences Corporation 31614.11.1 Company Overview 31614.12 C. R. Bard, Inc. 31714.12.1 Company Overview 31714.13 AGA Medical Holdings, Inc. 31714.13.1 Company Overview 31714.14 Asahi Intecc Co., Ltd. 31814.14.1 Company Overview 31814.15 GE Healthcare 31814.15.1 Company Overview 31814.16 Fukuda Denshi Co., Ltd. 31914.16.1 Company Overview 319
  6. 6. 14.17 Eurocor GmbH 31914.17.1 Company Overview 31914.18 Biosensors International Group, Ltd. 31914.18.1 Company Overview 31914.19 Philips Healthcare 32014.19.1 Company Overview 32014.20 Welch Allyn Inc. 32014.20.1 Company Overview 32014.21 OSI Systems, Inc. 32014.21.1 Company Overview 32014.22 Cardiac Science Corporation 32114.22.1 Company Overview 32114.23 Schiller AG 32114.23.1 Company Overview 32114.24 B. Braun Melsungen AG 32114.24.1 Company Overview 32114.25 Thoratec Corporation 32214.25.1 Company Overview 32214.26 Zoll Medical Corporation 32214.26.1 Company Overview 32214.27 Berlin Heart GmbH 32214.27.1 Company Overview 32214.28 ev3 Inc. 32314.28.1 Company Overview 32314.29 Teleflex Incorporated 32314.29.1 Company Overview 32314.30 HeartWare International, Inc. 32414.30.1 Company Overview 32414.31 Opto Circuits India Limited 32414.31.1 Company Overview 32414.32 Nihon Kohden Corporation 32514.32.1 Company Overview 32514.33 CareFusion Corporation 32514.33.1 Company Overview 32514.34 Covidien plc 32614.34.1 Company Overview 32614.35 Cook Medical Incorporated 32614.35.1 Company Overview 32615 Appendix 32715.1 Global Markets Direct Research Methodology 32715.2 Definitions of Markets Covered in the Report 32815.2.1 Cardiovascular Devices 328
  7. 7. 15.3 Secondary Research 34215.4 Primary Research 34215.5 Models 34315.6 Forecasts 34315.7 Expert Panel Validation 34315.8 Currency Conversion 34415.9 Contact Us 34415.10 Disclaimer 3441.1 List of TablesTable 1: Cardiovascular Devices, Egypt, Overall Revenue ($m), USD Constant, 2004-2018 21Table 2: Cardiovascular Devices, Egypt, Overall Revenue ($m), USD Constant, Historic, 2004-2011 23Table 3: Cardiovascular Devices, Egypt, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 25Table 4: Cardiovascular Devices, Egypt, Company Share by Revenue ($m), USD Constant, 2010-2011 27Table 5: Cardiac Assist Devices, Egypt, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 29Table 6: Cardiac Assist Devices, Egypt, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 31Table 7: Intra-Aortic Balloon Pumps, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 33Table 8: Intra-Aortic Balloon Pumps, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 35Table 9: Ventricular Assist Devices, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 37Table 10: Ventricular Assist Devices, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 39Table 11: Cardiac Assist Devices, Egypt, Volume (Units) by Segment, Historic, 2004-2011 40Table 12: Cardiac Assist Devices, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 41Table 13: Intra-Aortic Balloon Pumps, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-201143Table 14: Intra-Aortic Balloon Pumps, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 44Table 15: Ventricular Assist Devices, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-201145Table 16: Ventricular Assist Devices, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 46Table 17: Cardiac Assist Devices, Egypt, Average Price ($), Historic, 2004-2011 47Table 18: Cardiac Assist Devices, Egypt, Average Price ($), Forecast, 2011-2018 47Table 19: Cardiac Assist Devices, Egypt, Distribution Share by Revenue ($m), USD Constant,
  8. 8. 2010-2011 48Table 20: Cardiac Assist Devices, Egypt, Company Share by Revenue ($m), USD Constant, 2010-2011 50Table 21: Cardiac Rhythm Management, Egypt, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 52Table 22: Cardiac Rhythm Management, Egypt, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 54Table 23: Cardiac Resynchronisation Therapy, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 56Table 24: Cardiac Resynchronisation Therapy, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 58Table 25: Implantable Cardioverter Defibrillators, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 60Table 26: Implantable Cardioverter Defibrillators, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 62Table 27: Pacemakers, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 64Table 28: Pacemakers, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 66Table 29: Cardiac Rhythm Management, Egypt, Volume (Units) by Segment, Historic, 2004-201168Table 30: Cardiac Rhythm Management, Egypt, Volume (Units) by Segment, Forecast, 2011-201870Table 31: Cardiac Resynchronisation Therapy, Egypt, Volume (Units) by Sub-Segment, Historic,2004-2011 72Table 32: Cardiac Resynchronisation Therapy, Egypt, Volume (Units) by Sub-Segment, Forecast,2011-2018 74Table 33: Implantable Cardioverter Defibrillators, Egypt, Volume (Units) by Sub-Segment, Historic,2004-2011 76Table 34: Implantable Cardioverter Defibrillators, Egypt, Volume (Units) by Sub-Segment,Forecast, 2011-2018 78Table 35: Pacemakers, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 80Table 36: Pacemakers, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 81Table 37: Cardiac Rhythm Management, Egypt, Average Price ($), Historic, 2004-2011 82Table 38: Cardiac Rhythm Management, Egypt, Average Price ($), Forecast, 2011-2018 83Table 39: Cardiac Rhythm Management, Egypt, Distribution Share by Revenue ($m), USDConstant, 2010-2011 84Table 40: Cardiac Rhythm Management, Egypt, Company Share by Revenue ($m), USDConstant, 2010-2011 86Table 41: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Revenue ($m) USDConstant, by Segment, Historic, 2004-2011 88Table 42: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Revenue ($m) USD
  9. 9. Constant, by Segment, Forecast, 2011-2018 90Table 43: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Volume (Units) by Segment,Historic, 2004-2011 92Table 44: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Volume (Units) by Segment,Forecast, 2011-2018 94Table 45: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Average Price ($), Historic,2004-2011 95Table 46: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Average Price ($), Forecast,2011-2018 95Table 47: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Distribution Share byRevenue ($m), USD Constant, 2010-2011 96Table 48: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Company Share by Revenue($m), USD Constant, 2010-2011 98Table 49: Cardiovascular Prosthetic Devices, Egypt, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 100Table 50: Cardiovascular Prosthetic Devices, Egypt, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 102Table 51: Septal Occluders, Egypt, Revenue ($m*) USD Constant, by Sub-Segment, Historic,2004-2011 104Table 52: Septal Occluders, Egypt, Revenue ($m*) USD Constant, by Sub-Segment, Forecast,2011-2018 106Table 53: Cardiovascular Prosthetic Devices, Egypt, Volume (Units) by Segment, Historic, 2004-2011 108Table 54: Cardiovascular Prosthetic Devices, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 110Table 55: Septal Occluders, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 112Table 56: Septal Occluders, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 114Table 57: Cardiovascular Prosthetic Devices, Egypt, Average Price ($), Historic, 2004-2011 115Table 58: Cardiovascular Prosthetic Devices, Egypt, Average Price ($), Forecast, 2011-2018 115Table 59: Cardiovascular Prosthetic Devices, Egypt, Distribution Share by Revenue ($m), USDConstant, 2010-2011 116Table 60: Cardiovascular Prosthetic Devices, Egypt, Company Share by Revenue ($m), USDConstant, 2010-2011 118Table 61: Cardiovascular Surgery, Egypt, Revenue ($m*) USD Constant, by Segment, Historic,2004-2011 120Table 62: Cardiovascular Surgery, Egypt, Revenue ($m*) USD Constant, by Segment, Forecast,2011-2018 122Table 63: Beating Heart Surgery Systems, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 124Table 64: Beating Heart Surgery Systems, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 126Table 65: Perfusion Disposables, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic,
  10. 10. 2004-2011 128Table 66: Perfusion Disposables, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 130Table 67: Cardiovascular Surgery, Egypt, Volume (Units) by Segment, Historic, 2004-2011 132Table 68: Cardiovascular Surgery, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 134Table 69: Beating Heart Surgery Systems, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 136Table 70: Beating Heart Surgery Systems, Egypt, Volume (Units) by Sub-Segment, Forecast,2011-2018 138Table 71: Perfusion Disposables, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 140Table 72: Perfusion Disposables, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018142Table 73: Cardiovascular Surgery, Egypt, Average Price ($), Historic, 2004-2011 143Table 74: Cardiovascular Surgery, Egypt, Average Price ($), Forecast, 2011-2018 143Table 75: Cardiovascular Surgery, Egypt, Distribution Share by Revenue ($m), USD Constant,2010-2011 144Table 76: Cardiovascular Surgery, Egypt, Company Share by Revenue ($m), USD Constant,2010-2011 146Table 77: Electrophysiology, Egypt, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 148Table 78: Electrophysiology, Egypt, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 150Table 79: Electrophysiology Diagnostic Catheters, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 152Table 80: Electrophysiology Diagnostic Catheters, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 154Table 81: Electrophysiology Ablation Catheters, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 156Table 82: Electrophysiology Ablation Catheters, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 158Table 83: Electrophysiology, Egypt, Volume (Units) by Segment, Historic, 2004-2011 160Table 84: Electrophysiology, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 161Table 85: Electrophysiology Diagnostic Catheters, Egypt, Volume (Units) by Sub-Segment,Historic, 2004-2011 163Table 86: Electrophysiology Diagnostic Catheters, Egypt, Volume (Units) by Sub-Segment,Forecast, 2011-2018 165Table 87: Electrophysiology Ablation Catheters, Egypt, Volume (Units) by Sub-Segment, Historic,2004-2011 167Table 88: Electrophysiology Ablation Catheters, Egypt, Volume (Units) by Sub-Segment, Forecast,2011-2018 169Table 89: Electrophysiology, Egypt, Average Price ($), Historic, 2004-2011 170Table 90: Electrophysiology, Egypt, Average Price ($), Forecast, 2011-2018 170
  11. 11. Table 91: Electrophysiology, Egypt, Distribution Share by Revenue ($m), USD Constant, 2010-2011 171Table 92: Electrophysiology, Egypt, Company Share by Revenue ($m), USD Constant, 2010-2011173Table 93: External Defibrillators, Egypt, Revenue ($m*) USD Constant, by Segment, Historic,2004-2011 175Table 94: External Defibrillators, Egypt, Revenue ($m*) USD Constant, by Segment, Forecast,2011-2018 177Table 95: External Defibrillators, Egypt, Volume (Units) by Segment, Historic, 2004-2011 179Table 96: External Defibrillators, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 181Table 97: External Defibrillators, Egypt, Average Price ($), Historic, 2004-2011 182Table 98: External Defibrillators, Egypt, Average Price ($), Forecast, 2011-2018 182Table 99: External Defibrillators, Egypt, Distribution Share by Revenue ($m), USD Constant, 2010-2011 183Table 100: External Defibrillators, Egypt, Company Share by Revenue ($m), USD Constant, 2010-2011 185Table 101: Interventional Cardiology, Egypt, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 187Table 102: Interventional Cardiology, Egypt, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 189Table 103: Cardiac Catheters, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 191Table 104: Cardiac Catheters, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 193Table 105: Coronary Stents, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 195Table 106: Coronary Stents, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 197Table 107: PTCA Balloons, Egypt, Revenue ($m*) USD Constant, by Sub-Segment, Historic,2004-2011 199Table 108: PTCA Balloons, Egypt, Revenue ($m*) USD Constant, by Sub-Segment, Forecast,2011-2018 201Table 109: Arteriotomy Closure Devices, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 203Table 110: Arteriotomy Closure Devices, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 205Table 111: Intravascular Ultrasound Systems (IVUS), Egypt, Revenue ($m*) USD Constant, bySub-Segment, Historic, 2004-2011 207Table 112: Intravascular Ultrasound Systems (IVUS), Egypt, Revenue ($m*) USD Constant, bySub-Segment, Forecast, 2011-2018 209Table 113: Interventional Cardiology, Egypt, Volume (Units) by Segment, Historic, 2004-2011 211Table 114: Interventional Cardiology, Egypt, Volume (Units) by Segment, Forecast, 2011-2018
  12. 12. 213Table 115: Cardiac Catheters, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 215Table 116: Cardiac Catheters, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 216Table 117: Coronary Stents, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 218Table 118: Coronary Stents, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 219Table 119: PTCA Balloons, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 221Table 120: PTCA Balloons, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 223Table 121: Arteriotomy Closure Devices, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 225Table 122: Arteriotomy Closure Devices, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 227Table 123: Intravascular Ultrasound Systems (IVUS), Egypt, Volume (Units) by Sub-Segment,Historic, 2004-2011 229Table 124: Intravascular Ultrasound Systems (IVUS), Egypt, Volume (Units) by Sub-Segment,Forecast, 2011-2018 231Table 125: Interventional Cardiology, Egypt, Average Price ($), Historic, 2004-2011 232Table 126: Interventional Cardiology, Egypt, Average Price ($), Forecast, 2011-2018 233Table 127: Interventional Cardiology, Egypt, Distribution Share by Revenue ($m), USD Constant,2010-2011 234Table 128: Interventional Cardiology, Egypt, Company Share by Revenue ($m), USD Constant,2010-2011 236Table 129: Peripheral Vascular Devices, Egypt, Revenue ($m*) USD Constant, by Segment,Historic, 2004-2011 238Table 130: Peripheral Vascular Devices, Egypt, Revenue ($m*) USD Constant, by Segment,Forecast, 2011-2018 240Table 131: Stent Grafts, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 242Table 132: Stent Grafts, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 244Table 133: Inferior Vena Cava Filters (IVCF), Egypt, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011 246Table 134: Inferior Vena Cava Filters (IVCF), Egypt, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018 248Table 135: Peripheral Guidewires, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 250Table 136: Peripheral Guidewires, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 252Table 137: Peripheral Vascular Stents, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 254Table 138: Peripheral Vascular Stents, Egypt, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 256Table 139: Peripheral Embolic Protection Devices, Egypt, Revenue ($m*) USD Constant, by Sub-
  13. 13. Segment, Historic, 2004-2011 258Table 140: Peripheral Embolic Protection Devices, Egypt, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018 260Table 141: Peripheral Vascular Devices, Egypt, Volume (Units) by Segment, Historic, 2004-2011262Table 142: Peripheral Vascular Devices, Egypt, Volume (Units) by Segment, Forecast, 2011-2018264Table 143: Stent Grafts, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 266Table 144: Stent Grafts, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 267Table 145: Inferior Vena Cava Filters (IVCF), Egypt, Volume (Units) by Sub-Segment, Historic,2004-2011 269Table 146: Inferior Vena Cava Filters (IVCF), Egypt, Volume (Units) by Sub-Segment, Forecast,2011-2018 271Table 147: Peripheral Guidewires, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011272Table 148: Peripheral Guidewires, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018274Table 149: Peripheral Vascular Stents, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 276Table 150: Peripheral Vascular Stents, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 278Table 151: Peripheral Embolic Protection Devices, Egypt, Volume (Units) by Sub-Segment,Historic, 2004-2011 280Table 152: Peripheral Embolic Protection Devices, Egypt, Volume (Units) by Sub-Segment,Forecast, 2011-2018 282Table 153: Peripheral Vascular Devices, Egypt, Average Price ($), Historic, 2004-2011 283Table 154: Peripheral Vascular Devices, Egypt, Average Price ($), Forecast, 2011-2018 284Table 155: Peripheral Vascular Devices, Egypt, Distribution Share by Revenue ($m), USDConstant, 2010-2011 285Table 156: Peripheral Vascular Devices, Egypt, Company Share by Revenue ($m), USDConstant, 2010-2011 287Table 157: Prosthetic Heart Valves, Egypt, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 289Table 158: Prosthetic Heart Valves, Egypt, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 291Table 159: Mechanical Heart Valves, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 293Table 160: Mechanical Heart Valves, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 295Table 161: Tissue Heart Valves, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 297Table 162: Tissue Heart Valves, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
  14. 14. 2011-2018 299Table 163: Prosthetic Heart Valves, Egypt, Volume (Units) by Segment, Historic, 2004-2011 300Table 164: Prosthetic Heart Valves, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 301Table 165: Mechanical Heart Valves, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011303Table 166: Mechanical Heart Valves, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 304Table 167: Tissue Heart Valves, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 306Table 168: Tissue Heart Valves, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018307Table 169: Prosthetic Heart Valves, Egypt, Average Price ($), Historic, 2004-2011 308Table 170: Prosthetic Heart Valves, Egypt, Average Price ($), Forecast, 2011-2018 308Table 171: Prosthetic Heart Valves, Egypt, Distribution Share by Revenue ($m), USD Constant,2010-2011 309Table 172: Prosthetic Heart Valves, Egypt, Company Share by Revenue ($m), USD Constant,2010-2011 3111.2 List of FiguresFigure 1: Cardiovascular Devices, Egypt, Overall Revenue ($m), USD Constant, 2004-2018 20Figure 2: Cardiovascular Devices, Egypt, Overall Revenue ($m), USD Constant, Historic, 2004-2011 22Figure 3: Cardiovascular Devices, Egypt, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 24Figure 4: Cardiovascular Devices, Egypt, Company Share (%), 2011 26Figure 5: Cardiac Assist Devices, Egypt, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 28Figure 6: Cardiac Assist Devices, Egypt, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 30Figure 7: Intra-Aortic Balloon Pumps, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 32Figure 8: Intra-Aortic Balloon Pumps, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 34Figure 9: Ventricular Assist Devices, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 36Figure 10: Ventricular Assist Devices, Egypt, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 38Figure 11: Cardiac Assist Devices, Egypt, Volume (Units) by Segment, Historic, 2004-2011 40Figure 12: Cardiac Assist Devices, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 41Figure 13: Intra-Aortic Balloon Pumps, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 42Figure 14: Intra-Aortic Balloon Pumps, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 44
  15. 15. Figure 15: Ventricular Assist Devices, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-201145Figure 16: Ventricular Assist Devices, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 46Figure 17: Cardiac Assist Devices, Egypt, Company Share (%), 2011 49Figure 18: Cardiac Rhythm Management, Egypt, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 51Figure 19: Cardiac Rhythm Management, Egypt, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 53Figure 20: Cardiac Resynchronisation Therapy, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 55Figure 21: Cardiac Resynchronisation Therapy, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 57Figure 22: Implantable Cardioverter Defibrillators, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 59Figure 23: Implantable Cardioverter Defibrillators, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 61Figure 24: Pacemakers, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 63Figure 25: Pacemakers, Egypt, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 65Figure 26: Cardiac Rhythm Management, Egypt, Volume (Units) by Segment, Historic, 2004-201167Figure 27: Cardiac Rhythm Management, Egypt, Volume (Units) by Segment, Forecast, 2011-2018 69Figure 28: Cardiac Resynchronisation Therapy, Egypt, Volume (Units) by Sub-Segment, Historic,2004-2011 71Figure 29: Cardiac Resynchronisation Therapy, Egypt, Volume (Units) by Sub-Segment, Forecast,2011-2018 73Figure 30: Implantable Cardioverter Defibrillators, Egypt, Volume (Units) by Sub-Segment,Historic, 2004-2011 75Figure 31: Implantable Cardioverter Defibrillators, Egypt, Volume (Units) by Sub-Segment,Forecast, 2011-2018 77Figure 32: Pacemakers, Egypt, Volume (Units) by Sub-Segment, Historic, 2004-2011 79Figure 33: Pacemakers, Egypt, Volume (Units) by Sub-Segment, Forecast, 2011-2018 81Figure 34: Cardiac Rhythm Management, Egypt, Company Share (%), 2011 85Figure 35: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Revenue ($m) USDConstant, by Segment, Historic, 2004-2011 87Figure 36: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Revenue ($m) USDConstant, by Segment, Forecast, 2011-2018 89Figure 37: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Volume (Units) by Segment,Historic, 2004-2011 91
  16. 16. Figure 38: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Volume (Units) by Segment,Forecast, 2011-2018 93Figure 39: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Company Share (%), 201197Figure 40: Cardiovascular Prosthetic Devices, Egypt, Revenue ($m) USD Constant,Contact: sales@reportsandreports.com for more information.

×